“Advancements in Nanotechnology for Sustained Release Drugs”
A significant trend in the sustained release drugs market is the integration of nanotechnology. This innovation enhances drug delivery by improving the bioavailability and stability of medications over extended periods. Nanocarriers, such as liposomes, nanoparticles, and nanocapsules, are being employed to encapsulate drugs, ensuring they are released gradually in the body. For instance, the development of nanotechnology-based formulations for cancer therapies is gaining traction, such as the use of liposomal formulations in chemotherapy drugs such as Doxil. This technology allows for controlled release, minimizing side effects, and improving the therapeutic efficacy. The demand for more precise drug delivery systems, especially in chronic disease management, continues to drive the market’s growth.
